TURNING POINT THERAPEUTICS I (TPTX) Stock Earnings & Estimates
NASDAQ:TPTX - US90041T1088 - Common Stock
76.01 USD
+0.52 (+0.69%)
75.99 USD
-0.02 (-0.03%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 25M | 30.829M 23.32% | 6.796M -77.96% | 38.715M 469.70% | 219.562M 467.13% | 538.142M 145.10% | 1.345B 150.00% | ||
| EBITDA YoY % growth | -77.23M -202.86% | -160.96M -108.42% | -236.791M -47.11% | -298.059M -25.87% | -283.09M 5.02% | -34.441M 87.83% | -49.443M -43.56% | -72.398M -46.43% | |
| EBIT YoY % growth | -77.72M -203.12% | -161.84M -108.23% | -238M -47.06% | -341.306M -43.41% | -391.863M -14.81% | -336.136M 14.22% | -328.57M 2.25% | -327.598M 0.30% | |
| Operating Margin | N/A | -647.36% | -772.00% | -5,022.38% | -1,012.17% | -153.09% | -61.06% | -24.35% | |
| EPS YoY % growth | -5.88 | -3.07 47.79% | -4.79 -56.03% | -6.85 -43.06% | -7.35 -7.26% | -5.30 27.86% | -5.73 -8.13% | -6.32 -10.30% |
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.72 -28.64% | -1.77 -12.04% | -1.88 -25.12% | -1.96 -12.58% | -1.98 -14.79% | -1.98 -12.13% |
| Revenue Q2Q % growth | -100.00% | 5.051M | -100.00% | -100.00% | 4.82M | 11.858M 134.74% |
| EBITDA Q2Q % growth | -88.689M -34.77% | -49.909M 35.55% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -87.08M -30.65% | -90.058M -14.52% | -62.22M 16.97% | -100.47M 19.21% | -101.286M -16.31% | -98.124M -8.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -52.43% | -1.74 | % | |
| Q1 2022 Q2Q % growth | -1.50 -105.48% | -1.54 | 0.04 | 2.37% |
| Q4 2021 Q2Q % growth | -1.58 -54.90% | -1.42 | -0.16 | -11.37% |
| Q3 2021 Q2Q % growth | -1.34 -219.05% | -1.29 | -0.05 | -3.77% |
| Q2 2021 Q2Q % growth | -1.14 -39.02% | -1.24 | 0.10 | 7.80% |
| Q1 2021 Q2Q % growth | -0.73 9.88% | -0.62 | -0.11 | -17.91% |
| Q4 2020 Q2Q % growth | -1.02 -75.86% | -0.94 | -0.08 | -8.11% |
| Q3 2020 Q2Q % growth | -0.42 33.33% | -0.55 | 0.13 | 23.43% |
| Q2 2020 Q2Q % growth | -0.82 -17.14% | -0.91 | 0.09 | 9.67% |
| Q1 2020 Q2Q % growth | -0.81 79.60% | -0.67 | -0.14 | -20.06% |
| Q4 2019 Q2Q % growth | -0.58 | -0.65 | 0.07 | 10.80% |
| Q3 2019 Q2Q % growth | -0.63 | -0.56 | -0.07 | -12.01% |
| Q2 2019 Q2Q % growth | -0.70 | -0.66 | -0.04 | -6.23% |
| Q1 2019 Q2Q % growth | -3.97 | -0.71 | -3.26 | -462.04% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 119K -97.70% | 2.55M | -2.431M | -95.33% |
| Q1 2022 Q2Q % growth | 429K -98.30% | 429K | % | |
| Q4 2021 Q2Q % growth | 133.283K | -133.283K | -100.00% | |
| Q3 2021 Q2Q % growth | 460K -98.16% | 460K | % | |
| Q1 2021 Q2Q % growth | 25.21M | 22.313M | 2.898M | 12.99% |
| Q3 2020 Q2Q % growth | 25M | 12.75M | 12.25M | 96.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |